肿瘤标志物在卵巢癌早期诊断中的应用进展  

作　　者：陈玉梅[1] 王丽[1] 钟丽红[1] 刘瑶[1] 余志惠[1] 陈小娟[1] 

机构地区：[1]深圳市宝安区人民医院妇产科,518100

出　　处：《当代医学》2012年第20期12-13,共2页Contemporary Medicine

摘　　要：卵巢癌的死亡率在妇科疾病中占据首位,由于其早期症状不明显,在临床上也缺乏有效的早期诊断方法,很多患者在诊断出卵巢癌时已经是癌症晚期。早期患者的五年生存率在百分之九十以上,而晚期的却达不到百分之三十。由此可见,早期诊断对于卵巢癌患者的生存率至关重要。近几年,学者们一直在寻找具有高特异性和准确性的肿瘤标记物,以提高卵巢癌的早期诊断率,保证患者的有效预后。Ovarian cancer mortality in the gynecological diseases occupy the first place,because its early symptoms of obvious lack of effective methods for early diagnosis in clinical practice,many patients with advanced cancer has been diagnosed with ovarian cancer.The five-year survival rate of patients with early in more than 90% of late but less than 30 percent.This shows that early diagnosis is essential for the survival rate of patients with ovarian cancer.In recent years,scholars have been looking for a tumor marker with high specificity and accuracy,in order to improve the early diagnosis of ovarian cancer rates,to ensure effective prognosis of patients.

关 键 词：血清肿瘤标记物 卵巢癌 早期诊断 

分 类 号：R737.31[医药卫生—肿瘤]